Target Name: MIR3622A
NCBI ID: G100500858
Review Report on MIR3622A Target / Biomarker Content of Review Report on MIR3622A Target / Biomarker
MIR3622A
Other Name(s): mir-3622a | hsa-mir-3622a | MicroRNA 3622a | hsa-miR-3622a-5p | hsa-miR-3622a-3p | microRNA 3622a

MIR3622A: A Potential Drug Target and Biomarker

Molecular Intelligence (MOI) has identified a potential drug target and biomarker for the treatment of various diseases, including cancer. Specifically, MIR3622A, a nuclear transmembrane protein, has been identified as a potential drug target and biomarker for cancer, including breast cancer.

MIR3622A is a protein that is expressed in various tissues and organs, including the brain, pancreas, and gastrointestinal tract. It is a member of the heat shock protein (HSP) family and is involved in various cellular processes, including cell survival, metabolism, and stress responses.

Recent studies have suggested that MIR3622A may be a potential drug target for cancer. For example, MIR3622A has been shown to be involved in cell signaling pathways that are often disrupted in cancer, including the TGF-β pathway. TGF-β is a well-established pathway that is involved in cell growth, differentiation, and survival, and has been implicated in the development and progression of many types of cancer.

Furthermore, MIR3622A has been shown to be involved in the regulation of cellular stress responses, which are often increased in cancer cells. cellular stress responses are critical for maintaining cellular homeostasis and have been implicated in the development and progression of cancer.

MIR3622A may also be a potential biomarker for cancer, as it has been shown to be expressed in various types of cancer, including breast cancer. This suggests that MIR3622A may be a useful target for cancer diagnosis and treatment, as well as for the development of new biomarkers for cancer.

In conclusion, MIR3622A is a potential drug target and biomarker for cancer, including breast cancer. Further research is needed to fully understand its role in cancer biology and to develop effective treatments.

Protein Name: MicroRNA 3622a

The "MIR3622A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3622A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3622B | MIR363 | MIR3646 | MIR3648-1 | MIR3649 | MIR3650 | MIR3651 | MIR3652 | MIR3654 | MIR3655 | MIR3658 | MIR3659 | MIR365A | MIR365B | MIR3660 | MIR3661 | MIR3662 | MIR3663 | MIR3664 | MIR3665 | MIR3667 | MIR3667HG | MIR3668 | MIR367 | MIR3670-1 | MIR3670-2 | MIR3671 | MIR3672 | MIR3674 | MIR3675 | MIR3677 | MIR3678 | MIR3679 | MIR3680-1 | MIR3680-2 | MIR3681 | MIR3681HG | MIR3682 | MIR3683 | MIR3685 | MIR3686 | MIR3687 | MIR3688-1 | MIR3688-2 | MIR3689A | MIR3689B | MIR3689C | MIR3689D1 | MIR3689D2 | MIR3689F | MIR369 | MIR3690 | MIR3691 | MIR3692 | MIR370 | MIR3713 | MIR3714 | MIR371A | MIR371B | MIR372 | MIR373 | MIR374A | MIR374B | MIR374C | MIR375 | MIR376A1 | MIR376A2 | MIR376B | MIR376C | MIR377 | MIR378A | MIR378B | MIR378C | MIR378D1 | MIR378D2 | MIR378E | MIR378F | MIR378G | MIR378H | MIR378I | MIR379 | MIR380 | MIR381 | MIR382 | MIR383 | MIR384 | MIR3907 | MIR3908 | MIR3909 | MIR3910-1 | MIR3910-2 | MIR3911 | MIR3912 | MIR3913-1 | MIR3913-2 | MIR3914-1 | MIR3914-2 | MIR3915 | MIR3916 | MIR3917